[1]. Barman, D., Nen, P., Mandal, S.C., and Kumar, V. (2013). Immunostimulants for aquaculture health management, Journal of Marine Science: Research and Development, Vol.3, No. 3, PP. 1-11.
[2]. Thanigaive. S., Chandrasekaran, N., Mukherjee, A., and Thomas, J. (2016). Seaweeds as an alternative therapeutic source for aquatic disease management, Aquaculture, Vol .464, PP. 529-536.
[3]. Ma, K., Bao, Q., Wu, Y., Chen, S., Zhao, S., Wu, H., and Fan, J. (2020).
Evaluation of microalgae as immunostimulants and recombinant vaccines for diseases prevention and control in aquaculture, Frontiers in Bioengineering and Biotechnology, Vol.8, PP. 590431.
[4]. Sakai, M. (1999). Current research status of fish immunostimulants, Aquaculture, Vol.172, No.1-2, PP.63-92.
[5]. Balcázar, J.L., Blas, I., Ruizz Zarzuela, I., Cunningham, D., Vendrell, D., and Muzquiz, J.L. (2006). The role of the probiotics in aquaculture, Veterinary Microbioogy, Vol.003, PP. 024-082.
[6]. Adel, M., Yeganeh, S., Dadar, M., Sakai, M., and Dawood, M.A.O. (2016). Effects of dietary Spirulina platensis on growth performance, humoral and mucosal immune responses and disease resistance in juvenile great sturgeon (Huso huso Linnaeus, 1754), Fish and Shellfish Immunology, Vol.56, PP.436-444.
[7]. Riccio, G., and
Lauritano, C. (2020). Microalgae with Immunomodulatory Activities, Marine Drugs, Vol.18, No.1, PP. 2.
[8]. Medzhitov, R. (2007). Recognition of microorganisms and activation of the immune response, Nature, Vol.449, PP. 819–826.
[9]. Chan, A.H., and Schroder, K. (2019). Inflammasome signaling and regulation of interleukin-1 family cytokines, Journal of Experimental Medicine, Vol.217, PP. 20190314.
[10]. Magnadottir, B. (2010). Immunological control of fish diseases, Marine Biotechnology, Vol.12, PP. 361-379.
[11]. Spolaore, P., Joannis-Cassan, C., Duran, E., and Isambert, A. (2006). Commercial applications of microalgae, Journal of Bioscience and Bioengineering, Vol.101, No.2, PP.87-96.
[12]. Moreno-Garcia, L., Adjallé, K., Barnabé, S., and Raghavan, G.S.V. (2017). Microalgae biomass production for a biorefinery system: recent advances and the way towards sustainability, Renewable and Sustainable Energy Reviews, Vol.76, PP.493-506.
[13]. Bahi, A., Ramos-Vega, A., Angulo, C., Monreal-Escalante, E., and Guardiola, F.A. (2023). Microalgae with immunomodulatory effects on fish, Reviews in Aquaculture, Vol.15, No.4, PP. 1522-1539.
[14]. Ugwu, C.U., Aoyagi, H., and Uchiyama, H. (2008). Photobioreactors for mass cultivation of algae, Bioresource Technology, Vol.99, PP. 4021–4028.
[15]. Mimouni, V., Ulmann, L., Pasquet, V., Mathieu, M., Picot, L., Bougaran, G., Cadoret, J.P., Morant-Manceau, A., and Schoefs, B. (2012). The potential of microalgae for the production of bioactive molecules of pharmaceutical interest, Current Pharmaceutical Biotechnology, Vol.13, PP. 2733–2750.
[16].Shirmohammadi, M., Salamat, N., Ronagh, M.T., Movahedinia, A., and Hamidian, G. (2018). Using cell apoptosis, micronuclei and immune alternations as biomarkers of phenanthrene exposure in yellowfin seabream (Acanthopagrus latus),
Fish and Shellfish Immunology, Vol.72, PP.37-47.
[17]. Shirmohammadi, M., Chupani, L., and Salamat, N., (2017). Responses of immune organs after single-dose exposure to phenanthrene in yellowfin seabream (Acanthopagrus latus): CYP1A induction and oxidative stress,
Chemosphere, Vol. 186, No.2, PP.686-694.
[18]. Shirmohammadi, M., Salamat, N., Ronagh, M.T., Movahedinia, A., and Hamidian, G. (2017). Assessment of immune status of yellowfin seabream (Acanthopagrus latus) during short term exposure to phenanthrene, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, Vol.195, PP.78-90.
[19]. Kianersi, f., Salamat, N., Safahieh, A., Salati, A.P., and Houshmand, H. (2022). Comparative effects of organic and mineral selenium on mercury chloride-induced oxidative stress and liver tissue damages in juvenile yellowfin seabream (Acanthopagrus latus), Aquaculture Research, Vol. 53, No. 9, PP. 3478-3493.
[20]. Ibrahim, T.N.B.T., Feisal, N.A.S., Kamaludin, N.H., Cheah, W.Y., and How, V. (2023). Biological active metabolites from microalgae for healthcare and pharmaceutical industries: A comprehensive review, Bioresource Technology, Vol.372, PP. 128661.
[21]. Manuell, A.L., and Mayfield, S.P. (2006). A bright future for Chlamydomonas, Genome Biology, Vol.7, No.9, PP.327.
[22]. Kwon, K. C., Lamb, A., Fox, D., and Porphy Jegathese, S. J. (2019). An evaluation of microalgae as a recombinant protein oral delivery platform for fish using green fluorescent protein (GFP), Fish and Shellfish Immunology, Vol.87, PP. 414–420.
[23]. Siripornadulsil, S., Dabrowski, K., and Sayre, R. (2007). Microalgal vaccines, Advances in Experimental Medicine and Biology, Vol.616, PP.122–128.
[24]. Michelet, L., Lefebvre-Legendre, L., Burr, S. E., Rochaix, J. D., and Goldschmidt- Clermont, M. (2011). Enhanced chloroplast transgene expression in a nuclear mutant of Chlamydomonas, Plant Biotechnology Journal, Vol.9, PP. 565–574.
[25]. Feng, S., Feng, W., Zhao, L., Gu, H., Li, Q., and Shi, K. (2014). Preparation of transgenic Dunaliella salina for immunization against white spot syndrome virus in crayfish, Archives of Virology, Vol.159, PP. 519–525.
[26]. Zhai, Y., Shi, D., He, P., Cai, C., Yin, R., and Jia, R. (2019). Effect of transvp28 gene Synechocystis sp. PCC6803 on growth and immunity of Litopenaeus vannamei and defense against white spot syndrome virus (WSSV), Aquaculture, Vol.512, PP.734306.
[27]. Charoonnart, P., Worakajit, N., Zedler, J. A. Z., Meetam, M., Robinson, C., and Saksmerprome, V. (2019). Generation of microalga Chlamydomonas reinhardtii expressing shrimp antiviral dsRNA without supplementation of antibiotics, Scientific Reports, Vol.9, PP.3164.
[28]. Chen, Y. Y., Chen, J. C., Tayag, C. M., Li, H. F., Putra, D. F., and Kuo, Y. H. (2016). Spirulina elicits the activation of innate immunity and increases resistance against Vibrio alginolyticus in shrimp, Fish and Shellfish Immunology, Vol.55, PP.690–698.
[29]. Tsai, H. J., and Li, S.S. (2011). Nucleic Acid for use in Algae and use Thereof. United States: US 2011/0014708 A1. Washington, DC: U.S. Patent and Trademark Office.
[30]. Kim, M.J., Kim S.Y., Kim H.K., and Yoo, S.S. (2023). High-Level Expression of Recombinant VHSV Glycoprotein Using Transformed C. vulgaris and Verification of Vaccine Efficacy, Vaccines, Vol.11, No.7, PP.1205.
[31]. Kim, M.-J., Kim, S.-H., Kim, J.-O., Lee, T.-K., Jang, I.-K., and Choi, T.-J. (2023). Efficacy of White Spot Syndrome Virus Protein VP28-Expressing Chlorella vulgaris as an Oral Vaccine for Shrimp, Viruses, Vol.15, PP. 2010.
[32]. Leon-Banares, R., Gonzalez-Ballester, D., Galvan, A., and Fernandez, E. (2004). Transgenic microalgae as green cell-factories, Trends in Biotechnology, Vol.22, PP. 45–52.
[33]. Mutoloki, S., Munangandu, H.M., and Evensen, O. (2015). Oral vaccination of fish antigen preparations, uptake, and immune induction, Frontiers in Immunology, Vol.6, PP.519
